BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of ...

Most Americans 50 and older don't place much trust in health advice generated by artificial intelligence, a new survey finds.

Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...

Enrollment in a 2025 Medicare plan opened for beneficiaries today. News outlets focus on an array of changes that could lead to "benefit disruption" that consumers should know about, in particular ...

New research suggests that Medicare could save up to 74 percent of the money lost from discarded Alzheimer's drug Leqembi or ...

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...

An estimated $133 million to $336 million worth of lecanemab may be discarded every year. Adding a 75-mg vial could save ...

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...

Since Leqembi is dosed based on a patient’s weight and offered in single-use vials, about 5.8% of the drug dispensed will be ...

Lecanemab (Leqembi; Eisai/Biogen) received traditional approval from the FDA in July 2023, following an accelerated approval ...

Shelhorn explained, “This is why early detection and diagnosis of Alzheimer's is more important than ever. According to a 2023 news release by Eisai, the manufacturers of LEQEMBI™( lecanemab ...